Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
T., McConnell, A
2 The management of obesity continues to evolve with the approval of new treatments
This double-blind, placebo-controlled trial randomized (1:1) adults with body mass index 30 or 27 kg/m 2 and at least one obesity-related complication (excluding diabetes), who achieved 5.0% weight reduction after a 12-week intensive lifestyle intervention, to tirzepatide maximum tolerated dose (10 or 15 mg) or placebo once weekly for 72 weeks ( n = 579)
April 16, 2026
or another serious condition your doctor has linked to your use of the drug
US$ 29.71
US$ 28.57
US$ 27.05
US$ 27.48
US$ 24.43
US$ 25.63
US$ 25.92
US$ 29.62
US$ 23.45
